First Time Loading...

Oncotelic Therapeutics Inc
OTC:OTLC

Watchlist Manager
Oncotelic Therapeutics Inc Logo
Oncotelic Therapeutics Inc
OTC:OTLC
Watchlist
Price: 0.037 USD Market Closed
Updated: Jun 6, 2024

Oncotelic Therapeutics Inc
Long-Term Debt

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Oncotelic Therapeutics Inc
Long-Term Debt Peer Comparison

Comparables:
ABBV
GILD
AMGN
VRTX
REGN

Competitive Long-Term Debt Analysis
Latest Figures & CAGR of Competitors

Company Long-Term Debt CAGR 3Y CAGR 5Y CAGR 10Y
Oncotelic Therapeutics Inc
OTC:OTLC
Long-Term Debt
$1.9m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Abbvie Inc
NYSE:ABBV
Long-Term Debt
$63.8B
CAGR 3-Years
-5%
CAGR 5-Years
13%
CAGR 10-Years
16%
Gilead Sciences Inc
NASDAQ:GILD
Long-Term Debt
$21.5B
CAGR 3-Years
-8%
CAGR 5-Years
-2%
CAGR 10-Years
10%
Amgen Inc
NASDAQ:AMGN
Long-Term Debt
$60.1B
CAGR 3-Years
24%
CAGR 5-Years
15%
CAGR 10-Years
7%
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Long-Term Debt
$361.5m
CAGR 3-Years
-12%
CAGR 5-Years
-8%
CAGR 10-Years
-4%
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
Long-Term Debt
$2.7B
CAGR 3-Years
11%
CAGR 5-Years
31%
CAGR 10-Years
18%

See Also

What is Oncotelic Therapeutics Inc's Long-Term Debt?
Long-Term Debt
1.9m USD

Based on the financial report for Dec 31, 2023, Oncotelic Therapeutics Inc's Long-Term Debt amounts to 1.9m USD.